The harbinger of mortality in heart failure with preserved ejection fraction: do GDF-15 levels reflect tandem, deterministic effects of fibrosis and inflammation?

Can J Cardiol. 2014 Mar;30(3):264-6. doi: 10.1016/j.cjca.2013.12.021. Epub 2014 Jan 1.

Authors

Brendan N Putko¹, Haran Yogasundaram¹, Gavin Y Oudit²

Affiliations

¹ Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
² Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: [email protected].

PMID: 24565250
DOI: 10.1016/j.cjca.2013.12.021

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Female
Growth Differentiation Factor 15 / blood*
Heart Failure / blood*
Humans
Male
Stroke Volume / physiology*
Ventricular Function, Left / physiology*

Substances

Growth Differentiation Factor 15

Grants and funding

Canadian Institutes of Health Research/Canada